CYSTINOSIS RESEARCH FOUNDATION: Form 990, tax year 2016

View the entire original 990 at ProPublica ↗

Organization
CYSTINOSIS RESEARCH FOUNDATION (EIN 32-0067668)
Tax period
2016-01-01 to 2016-12-31
Filed
2017-10-05
IRS object ID
201742789349300929
Schema version
2016v3.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2017-10-05T11:50:40-07:00ReturnTs
Tax Period End2016-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1Montgomery Glick & CompanyBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line123801 Calabasas Rd Ste 103AddressLine1Txt
CityCalabasasCityNm
State AbbreviationCAStateAbbreviationCd
ZIP91302ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2016-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN320067668EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1CYSTINOSIS RESEARCH FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlCYSTBusinessNameControlTxt
Phone9492237610PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line118802 BARDEEN AVEAddressLine1Txt
CityIRVINECityNm
State AbbreviationCAStateAbbreviationCd
ZIP92612ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonGEOFFREY STACKPersonNm
Person TitleTrusteePersonTitleTxt
Signature2017-10-05SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonPETER MONTGOMERYPreparerPersonNm
PTINP01209820PTIN
Phone8189996967PhoneNum
FieldValueIRS element (for citing)
Tax2016TaxYr
Build TS2021-01-29 14:40:06ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Gross Receipts$5,112,834GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
All Affiliates IncludedfalseAllAffiliatesIncludedInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.cystinosisresearch.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2003FormationYr
Legal Domicile StateCALegalDomicileStateCd
Activity Or MissionCRF'S MISSION IS TO SUPPORT BENCH, CLINICAL AND TRANSLATIONAL RESEARCH TO FIND BETTER TREATMENTS AND A CURE FOR CYSTINOSISActivityOrMissionDesc
Voting Members Governing Body21VotingMembersGoverningBodyCnt
Voting Members Independent21VotingMembersIndependentCnt
Total Employee1TotalEmployeeCnt
Total Gross UBI$0TotalGrossUBIAmt
PY Contributions Grants$3,213,127PYContributionsGrantsAmt
CY Contributions Grants$4,818,959CYContributionsGrantsAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$69,576PYInvestmentIncomeAmt
CY Investment Income$38,599CYInvestmentIncomeAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$3,282,703PYTotalRevenueAmt
CY Total Revenue$4,857,558CYTotalRevenueAmt
PY Grants And Similar Paid$1,895,803PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$1,580,936CYGrantsAndSimilarPaidAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$60,146PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$62,729CYSalariesCompEmpBnftPaidAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$600,799CYTotalFundraisingExpenseAmt
PY Other Expenses$842,413PYOtherExpensesAmt
CY Other Expenses$1,393,883CYOtherExpensesAmt
PY Total Expenses$2,798,362PYTotalExpensesAmt
CY Total Expenses$3,037,548CYTotalExpensesAmt
PY Revenues Less Expenses$484,341PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$1,820,010CYRevenuesLessExpensesAmt
Total Assets BOY$4,779,733TotalAssetsBOYAmt
Total Assets EOY$6,325,183TotalAssetsEOYAmt
Total Liabilities BOY$2,195,760TotalLiabilitiesBOYAmt
Total Liabilities EOY$1,802,763TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$2,583,973NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$4,522,420NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionCRF'S MISSION IS TO SUPPORT BENCH, CLINICAL AND TRANSLATIONAL RESEARCH TO FIND BETTER TREATMENTS AND A CURE FOR CYSTINOSISMissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$1,580,936ExpenseAmt
Grant$1,580,936GrantAmt
DescHISTORY - "NATALIE'S WISH"NATALIE'S WISH, 'TO HAVE MY DISEASE GO AWAY FOR EVER' - THOSE SEVEN WORDS PROVIDED THE INSPIRATION TO ESTABLISH THE CYSTINOSIS RESEARCH FOUNDATION (CRF) IN 2003. WE KNEW AT THAT MOMENT THAT WE NEEDED TO MAKE EVERY EFFORT TO MAKE NATALIE'S WISH - AND THE WISHES OF OTHERS WITH CYSTINOSIS - A REALITY.RESEARCHCystinosis is a rare, metabolic and genetic disease that afflicts approximately 2,000 children and adults worldwide. CRFs focus is increasingly on the clinical and translational research crucial to making strides towards a cure for cystinosis. CRF is committed to prioritizing and aggressively supporting research which has the potential to significantly improve the quality of life for patients with cystinosis. CRF announces two global calls for research proposals each year. After careful evaluation of every application by the CRF Scientific Review Board, research grants are awarded. In 2006, CRF established the first Cystinosis Research Fellowship Program designed to support scientists and new researchers who have an interest in cystinosis. RESEARCH GIVES US HOPEWe firmly believe that research gives us HOPE and hope allows us to live with cystinosis until the day a cure is found. Since 2003, the Cystinosis Research Foundation (CRF) has become the largest fund provider of cystinosis research in the world raising more than $39 million. CRF has changed the course of cystinosis by investing donors gifts strategically and aggressively to create a thriving research community. From the beginning, all CRF operating costs are privately underwritten so that 100 percent of the funds donated goes to support cystinosis research. We are pleased to announce that in 2016 CRF issued 10 new grants totaling more than $1.56 million for cystinosis research. An additional seven grant agreements were awarded prior to year-end totaling $1.39 million with the funding for these grants available in the cash reserves. The new grants bring us that much closer to better treatments and a cure.CRF has issued grants to the best and brightest researchers in the world. To date, we have funded 151 multi-year research studies at leading research institutions in 12 countries. CRF-funded researchers have published more than 67 articles in prestigious, top-rated journals. Those articles, available to everyone in the world, have added to the understanding of the pathogenesis of cystinosis. From the beginning, we have understood that funding basic and bench research was important to understanding cystinosis. Over the years, as discoveries were made in the lab, CRF began funding clinical research, and now we are translating the data from the clinical studies to the patients. One of our earliest milestones, and the one of which we are most proud, is that CRF funded every bench and clinical trial that led to the discovery of a delayed-release form of the life-saving medication cystinosis patients must take. The delayed-release medication, approved by the FDA in 2013, is considered the most significant advancement in the treatment of cystinosis in 30 years. Our latest research milestone is the creation of the first donor stem cell transplantation trial at UCLA, which brings us tantalizingly close to a cure. Moving forward, we have targeted several areas of research including muscle wasting, neurological issues, corneal cystinosis, and stem cell and gene therapy, all with the goal of finding better treatments and a cure for cystinosis.NANOTECHNOLOGY AND CORNEAL CYSTINOSISWe are dedicated to finding better treatments for corneal cystinosis. Corneal cystinosis is the build-up of cystine crystals in the eyes that causes photophobia (extreme sensitivity to light) severe eye pain, and sometimes, blindness. There is an existing treatment but it is rigorous and requires hourly dosing of medicated eye drops. For many, compliance is difficult. Ghanashyam Acharya, PhD, and Jennifer Simpson, MD, have collaborated on a novel treatment for corneal cystinosis. Dr. Acharya has invented a nanowafer that we believe will revolutionize the treatment of corneal cystinosis. The nanowafer can be loaded with cysteamine medication to treat corneal cystinosis. The nanowafer is placed in the eye, and as it dissolves, the medication slowly releases in the eye offering relief for hours. In 2016, CRF formed Corneal Cystinolysis, Inc., (CCI) for the purpose of research and development of a novel treatment for corneal cystinosis. The treatment proposes to use a nanowafer loaded with cysteamine medication to treat corneal cystinosis. CRF owns the license for the cysteamine nanowafer which ensures that we remain focused and committed to bringing the new treatment to the patients. The scientist who developed the nanowafer is Dr. Ghanshyam Acharya at Baylor College of Medicine. CRF and Dr. Acharya are committed to this project and hope to file a new drug application in 2018. STEM CELL AND GENE THERAPYWe believe that stem cells will be the cure for cystinosis. CRF works closely with Stphanie Cherqui, PhD, whose focus is stem cells and gene therapy. Dr. Cherqui has worked together with the FDA for several years and is awaiting FDA approval to commence the first autologous stem cell and gene therapy clinical trial. We are optimistic that the FDA will approve this study in 2017. Once it is approved, we can help recruit patients soon thereafter. Dr. Cherquis work is our hope; not only has the treatment reversed cystinosis in mice, last year she successfully cured corneal cystinosis in the mouse model. CYSTINOSIS RESEARCH HELPS OTHERSMany of the discoveries made by CRF researchers are currently being applied to other more prevalent and well-known disorders and diseases including other corneal diseases, kidney diseases and genetic and systemic diseases similar to cystinosis. Support for cystinosis research has reached far beyond the cystinosis community. A cure for cystinosis will help find cures for other diseases potentially helping millions of people. CRF FAMILIES AND PARTNERSThe Cystinosis Research Foundation has witnessed tremendous growth as other cystinosis families have joined our efforts. Their friends and families have embraced the cystinosis cause and enthusiastically raise funds to support cystinosis research through CRF. We have found strength in numbers and our joint effort gives us a renewed sense of community and purpose.DAY OF HOPE CONFERENCEEach year the Cystinosis Research Foundation hosts the Day of Hope Family Conference. In 2016, 56 families from around the world gathered along with CRF funded researchers to share stories, hopes and dreams and build life-long friendships. Leading cystinosis researchers shared their progress on gene and stem cell therapies, novel eye research and neurological challenges related to cystinosis. The conference allows families to learn more about the ongoing cystinosis research and the hope it brings to our community. CURE CYSTINOSIS INTERNATIONAL REGISTRYThe Cure Cystinosis International Registry (CCIR) was launched in 2010 and now has approximately 576 cystinosis patients registered from 44 countries. The Cystinosis Research Foundation in partnership and collaboration with the Cystinosis Foundation and twelve other cystinosis family foundations from around the world, established this comprehensive, global patient registry for cystinosis. The CCIR questionnaire was developed by medical and scientific experts specifically for the cystinosis community. To improve accessibility, the CCIR has been translated into Spanish, Portuguese, Dutch and French. It is our mission to register every person with cystinosis, thus connecting them to the research community in an effort to find a cure for cystinosis. The CCIR is a central hub of information and is an essential tool for the global cystinosis research community. We are certain that the information provided by the patients will accelerate the research process and unite us in our quest to find a cure for cystinosis. CRF INTERNATIONAL RESEARCH SYMPOSIUMCRFs International Research Symposium is held every two years and is only open to invited researchers and scientists. Approximately 65 cystinosis experts from leading international universities and research institutions gather to share their research data and to discuss cutting edge research ideas in an effort to accelerate research. The symposium is known for the openness of the attendees, and for their willingness to work together and form collaborations. The symposium has created a synergistic research community working in partnership with CRF.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$494,908ExpenseAmt

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

FieldValueIRS element (for citing)
Expense$208,493ExpenseAmt
FieldValueIRS element (for citing)
Total Program Service Expenses$2,284,337TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredfalseScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesfalseLobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundfalseDonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Temp Or Permanent EndowmentsfalseTempOrPermanentEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsfalseReportOtherAssetsInd
Report Other LiabilitiesfalseReportOtherLiabilitiesInd
Include FIN48 FootnotefalseIncludeFIN48FootnoteInd
Independent Audit Fincl StmtYes (true)IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgYes (true)MoreThan5000KToOrgInd
More Than5000 K To IndividualsfalseMoreThan5000KToIndividualsInd
Professional FundraisingfalseProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsfalseGrantsToIndividualsInd
Schedule J RequiredfalseScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Invest Tax Exempt BondsfalseInvestTaxExemptBondsInd
Escrow AccountfalseEscrowAccountInd
On Behalf Of IssuerfalseOnBehalfOfIssuerInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With Officer EntfalseBusinessRlnWithOfficerEntInd
Deductible Non Cash ContrifalseDeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityfalseRelatedEntityInd
Related Organization Ctrl EntfalseRelatedOrganizationCtrlEntInd
Transaction With Control EntfalseTransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document0IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld CompliancefalseBackupWthldComplianceInd
Employee1EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitfalseUnrelatedBusIncmOverLimitInd
Form990 T FiledfalseForm990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Form8282 Filed0Form8282FiledCnt
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
Form8899 FiledindfalseForm8899Filedind
Form1098 C FiledfalseForm1098CFiledInd
DAF Excess Business HoldingsfalseDAFExcessBusinessHoldingsInd
Taxable DistributionsfalseTaxableDistributionsInd
Distribution To DonorfalseDistributionToDonorInd
Org Filed In Lieu Of Form1041falseOrgFiledInLieuOfForm1041Ind
Licensed More Than One StatefalseLicensedMoreThanOneStateInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members21GoverningBodyVotingMembersCnt
Independent Voting Member21IndependentVotingMemberCnt
Family Or Business RlnYes (true)FamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsfalseChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersfalseMembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersfalseLocalChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOfalseCompensationProcessCEOInd
Compensation Process OtherfalseCompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonGEOFFREY STACKPersonNm
Phone9497565959PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line118802 BARDEEN AVEAddressLine1Txt
CityIRVINECityNm
State AbbreviationCAStateAbbreviationCd
ZIP92612ZIPCd
FieldValueIRS element (for citing)
No Listed Persons CompensatedYes (X)NoListedPersonsCompensatedInd

Form990 Part VII Section A Form990PartVIISectionAGrp (21 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmt
NANCY STACK
CHAIR - TRUSTEE40.000.00Yes (X)$0$0$0
GEOFFREY STACK
VICE CHAIR0.000.00Yes (X)$0$0$0
DONALD L SOLSBY
Trustee2.000.00Yes (X)$0$0$0
BRUCE CRAIR
Trustee0.000.00Yes (X)$0$0$0
STEPHANIE CHERQUI
Trustee0.000.00Yes (X)$0$0$0
MARCU ALEXANDER
Trustee0.000.00Yes (X)$0$0$0
DAVID W MOSSMAN
Trustee0.000.00Yes (X)$0$0$0
JOHN S HAGESTAD
Trustee0.000.00Yes (X)$0$0$0
ERIN LITTLE
Trustee0.000.00Yes (X)$0$0$0
MICHAEL K HAYDE
Trustee0.000.00Yes (X)$0$0$0
KRIS K ELFTMANN
Trustee0.000.00Yes (X)$0$0$0
KEVIN PARTINGTON
Trustee0.000.00Yes (X)$0$0$0
TERESA PARTINGTON
Trustee0.000.00Yes (X)$0$0$0
BRIAN STURGIS
Trustee0.000.00Yes (X)$0$0$0
ROBERT D OLSON
Trustee0.000.00Yes (X)$0$0$0
DENICE FLERCHINGER
Trustee0.000.00Yes (X)$0$0$0
JOHN C MANLY
Trustee0.000.00Yes (X)$0$0$0
JODY STRAUSS
Trustee0.000.00Yes (X)$0$0$0
THOMAS A GENDRON
Trustee0.000.00Yes (X)$0$0$0
TRACI GENDRON
Trustee0.000.00Yes (X)$0$0$0
STEPHEN L JENKINS MD
Trustee0.000.00Yes (X)$0$0$0
FieldValueIRS element (for citing)
Indiv Rcvd Greater Than100 K0IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KfalseTotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd
Cntrct Rcvd Greater Than100 K0CntrctRcvdGreaterThan100KCnt
Fundraising$2,602,043FundraisingAmt
All Other Contributions$2,216,916AllOtherContributionsAmt
Total Contributions$4,818,959TotalContributionsAmt
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$26,853TotalRevenueColumnAmt
Related Or Exempt Func Income$26,853RelatedOrExemptFuncIncomeAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$267,022SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$255,276SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$11,746SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$11,746TotalRevenueColumnAmt
Related Or Exempt Func Income$11,746RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Contri Rpt Fundraising Event$2,602,043ContriRptFundraisingEventAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Other Revenue Total$0OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$4,857,558TotalRevenueColumnAmt
Related Or Exempt Func Income$38,599RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$1,003,284TotalAmt
Program Services$1,003,284ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$577,652TotalAmt
Program Services$577,652ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$57,875TotalAmt
Fundraising$57,875FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$4,854TotalAmt
Fundraising$4,854FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$50,140TotalAmt
Program Services$2,948ProgramServicesAmt
Management And General$30,444ManagementAndGeneralAmt
Fundraising$16,748FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$135,057TotalAmt
Program Services$28,258ProgramServicesAmt
Fundraising$106,799FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$24,286TotalAmt
Program Services$1,031ProgramServicesAmt
Management And General$8,505ManagementAndGeneralAmt
Fundraising$14,750FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$8,036TotalAmt
Management And General$8,036ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmtFundraisingFundraisingAmt
CORNEAL CYSTINOSIS-NANOWAFER$270,623$270,623
EDUCATION$189,047$189,047
Printing and Publications$181,080$69,823$3,696$107,561
OUTSIDE SERVICES$162,932$29,250$46,377$87,305

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$372,682TotalAmt
Program Services$112,421ProgramServicesAmt
Management And General$55,354ManagementAndGeneralAmt
Fundraising$204,907FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$3,037,548TotalAmt
Program Services$2,284,337ProgramServicesAmt
Management And General$152,412ManagementAndGeneralAmt
Fundraising$600,799FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$3,565,590BOYAmt
EOY$4,672,285EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$112,500BOYAmt
EOY$63,746EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$123,678BOYAmt
EOY$122,507EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$56,838LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$56,838LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$977,965BOYAmt
EOY$1,466,645EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
EOY$0EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$4,779,733BOYAmt
EOY$6,325,183EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$75,547BOYAmt
EOY$63,761EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$2,120,213BOYAmt
EOY$1,739,002EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$2,195,760BOYAmt
EOY$1,802,763EOYAmt
FieldValueIRS element (for citing)
Organization Follows SFAS117Yes (X)OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

FieldValueIRS element (for citing)
BOY$2,583,973BOYAmt
EOY$4,522,420EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$2,583,973BOYAmt
EOY$4,522,420EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$4,779,733BOYAmt
EOY$6,325,183EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$1,820,010ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$118,437NetUnrlzdGainsLossesInvstAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Separate Basis Fincl StmtYes (X)SeparateBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$2,572,531CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,130,529CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,324,548CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,213,127CurrentTaxYearMinus1YearAmt
Current Tax Year$4,818,959CurrentTaxYearAmt
Total$17,059,694TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$2,572,531CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$3,130,529CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,324,548CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$3,213,127CurrentTaxYearMinus1YearAmt
Current Tax Year$4,818,959CurrentTaxYearAmt
Total$17,059,694TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$0SubstantialContributorsTotAmt
Public Support Total170$17,059,694PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$25,848CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$19,064CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$9,190CurrentTaxYearMinus2YearsAmt
Total$54,102TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt
FieldValueIRS element (for citing)
Total Support$17,113,796TotalSupportAmt
Public Support CY1700.99680PublicSupportCY170Pct
Public Support PY1700.93020PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule D IRS990ScheduleD

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$56,838OtherCostOrOtherBasisAmt
Depreciation$56,838DepreciationAmt
FieldValueIRS element (for citing)
Total Rev Etc Audited Fincl Stmt$4,857,558TotalRevEtcAuditedFinclStmtAmt
Revenue Subtotal$4,857,558RevenueSubtotalAmt
Total Revenue Per Form990$4,857,558TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt$3,037,548TotExpnsEtcAuditedFinclStmtAmt
Expenses Subtotal$3,037,548ExpensesSubtotalAmt
Total Expenses Per Form990$3,037,548TotalExpensesPerForm990Amt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (7 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
BELGIUM00GRANTSMEDICAL RESEARCH$0
FRANCE00GRANTSMEDICAL RESEARCH$26,400
INDIA00GRANTSMEDICAL RESEARCH$0
ITALY00GRANTSMEDICAL RESEARCH$180,400
NEW ZEALAND00GRANTSMEDICAL RESEARCH$145,852
SWITZERLAND00GRANTSMEDICAL RESEARCH$0
FRANCE00GRANTSMEDICAL RESEARCH$225,000
FieldValueIRS element (for citing)
Subtotal Spent$577,652SubtotalSpentAmt
Total Spent$577,652TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (7 entries)

Purpose Of GrantPurposeOfGrantTxtManner Of Cash DisbursementMannerOfCashDisbursementTxt
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
MEDICAL RESEARCHCHECK
FieldValueIRS element (for citing)
Total501c3 Org7Total501c3OrgCnt
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyfalseAgrmtProfFundraisingActyInd
Licensed StatesCALicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1ANNUAL FUNDRAISER - SEE NOTE (4)Event1Nm
Gross Receipts Event1$2,602,043GrossReceiptsEvent1Amt
Charitable Contri Event1$2,602,043CharitableContriEvent1Amt
Gross Receipts Total$2,602,043GrossReceiptsTotalAmt
Charitable Contributions Tot$2,602,043CharitableContributionsTotAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (7 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxt
HARVARD MEDICAL SCHOOL
A-111 25 SHATTUCK STBOSTONMA02115530199180$225,000$0MEDICAL RESEARCH
MASSACHUSETTS GENERAL HOSPITAL
101 HUNTINGTON AVENUE SUITE 300BOSTONMA02199041564655$96,129$0MEDICAL RESEARCH
REGENTS OF UCSD
9500 GILMAN DRIVE MC 0934LA JOLLACA92093946060626$141,082$0MEDICAL RESEARCH
THE SCRIPPS RESEARCH INSTITUT
10550 N TORREY PINES RDLA JOLLACA92307330435954$150,000$0MEDICAL RESEARCH
THE SCRIPPS RESEARCH INSTITUT
10550 N TORREY PINES ROADLA JOLLACA92037330435954$75,000$0MEDICAL RESEARCH
UNIVERSITY OF CALIFORNIA SD
9500 GILMAN DRIVE DEPT 0935LA JOLLACA92093956006144$160,589$0MEDICAL RESEARCH
UNIVERSITY OF PITTSBURGH SCHO
3550 TERRACE STPITTSBURGHPA15213113708851$155,484$0MEDICAL RESEARCH
FieldValueIRS element (for citing)
Total501c3 Org7Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Schedule L IRS990ScheduleL

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

FieldValueIRS element (for citing)
PersonKRIS ELFTMANNPersonNm
FieldValueIRS element (for citing)
Relationship DescriptionDIRECTORRelationshipDescriptionTxt
TransactionSEE NOTE (1)TransactionDesc
Sharing Of RevenuesfalseSharingOfRevenuesInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (23 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Client Note 1Client Note 1 - NOTE (1) - CONSOLIDATED STATEMENTSFORM 990 PART IV, 12(B)THE EXEMPT ORGANIZATION CONSOLIDATED FINANCIAL STATEMENTS INCLUDE THE ACCOUNTS OF CORNEAL CYSTINOLYSIS, INC (CCI), A TEXAS CORPORATION, OWNED 100% BY THE CYSTINOSIS RESEARCH FOUNDATION. THE EXEMPT ORGANIZATION RETURN INCLUDES AND IS BASED ON THE CONSOLIDATED ACCOUNTS.
Client Note 2Client Note 2 - NOTE (2) - SCHEDULE L - PART IVDIRECTOR KRIS ELFTMANN IS AN OWNER OF NOELLE CORPORATE COMMUNICATIONS WHICH PROVIDES MARKETING SERVICES AND PRODUCTS, SUCH AS MAGAZINE PUBLICATIONS TO THE FOUNDATION. THE COST OS SUCH SERVICES WAS APPROXIMATELY $30,000 IN 2016.NOTE (2)DIRECTOR DONALD SOLSBY'S WIFE, ZOE SOLSBY, IS A CONSULTANT TO THE FOUNDATION. MRS. SOLSBY RECEIVED COMPENSATION OF APPROXIMATELY $54,000 IN 2016.
Client Note 3Client Note 3 - NOTE (2) - FUNDRAISERSSCHEDULE G - PART II THE FOUNDATION HOLDS ANNUAL FUNDRAISING EVENTS. HOWEVER THE INCOME IS RECEIVED IN THE FORM OF CHARITABLE CONTRIBUTIONS AND SO NO SEPARATE ACCOUNTING HAS BEEN SHOWN ON SCHEDULE G. DIRECT COSTS OF THE FUNDRAISERS ARE SHOWN ON FORM 990, PART IX. CONTROL OF FUNDS IS MAINTAINED BY THE FOUNDATION AND NOT THIRD PARTY PROFESSIONAL FUNDRAISERS.
Client Note 4Client Note 4 - NOTE (4) FORM RRF-1, QUESTION 7THE FOUNDATION HELD A RAFFLE AT ITS ANNUAL GOLF TOURNAMENT ON OCTOBER 17, 2016. PROCEEDS FROM THE RAFFLE ARE INCLUDED IN THE FUNDRAISING INCOME ON FORM 990, PART VIII, LINE 1(C).
Form 990, Part VI, Line 2: Description of Business or Family Relationship of Officers, Directors, EtTRUSTEES, GEOFFREY AND NANCY STACK,ARE HUSBAND AND WIFE. DIRECTORS, KEVIN AND TERESA PARTINGTON, ARE HUSBAND AND WIFE.DIRECTORS, TRACI AND THOMAS GENDRON, ARE HUSBAND AND WIFE
Form 990, Part VI, Line 11b: Form 990 Review ProcessFORM 990 IS REVIEWED BY BOARD OF DIRECTORS PRIOR TO FILING. AUDITORS FOR THE FOUNDATION HAVE REVIEWED THE RETURN AND PROVIDED COMMENTS TO THE TAX PREPARER.
Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of ConflictsBOARD REVIEWS POSSIBLE CONFLICTS ON A REGULAR BASIS AND DISCLOSES REVIEW AT BOARD MEETINGS
Form 990, Part VI, Line 19: Other Organization Documents Publicly AvailableCRF MAINTAINS THE GOVERNING DOCUMENTS, POLICIES AND PROCEDURES AND FINANCIAL STATEMENTS AT ITS OFFICES IN IRVINE, CALIFORNIA. COPIES OF THESE DOCUMENTS ARE AVAILABLE TO THE PUBLIC UPON REQUEST. OUR FORM 990 IS POSTED ON OUR WEBSITE AND ON GUIDESTAR ON THE INTERNET.
Form 990, Part IX, Line 24e: Other ExpensesAUCTION ITEMS: Column (A) - Total = $10073; Column (B) - Program Services = $0; Column (C) - Management & General = $0; Column (D) - Fundraising = $10073
Form 990, Part IX, Line 24e: Other ExpensesCCI OTHER : Column (A) - Total = $4095; Column (B) - Program Services = $0; Column (C) - Management & General = $4095; Column (D) - Fundraising = $0
Form 990, Part IX, Line 24e: Other ExpensesCCI PROFESSIONAL FEES: Column (A) - Total = $22845; Column (B) - Program Services = $0; Column (C) - Management & General = $22845; Column (D) - Fundraising = $0
Form 990, Part IX, Line 24e: Other ExpensesCREDIT CARD FEES: Column (A) - Total = $27416; Column (B) - Program Services = $0; Column (C) - Management & General = $0; Column (D) - Fundraising = $27416
Form 990, Part IX, Line 24e: Other ExpensesGRANTS DISCOUNTED: Column (A) - Total = $924; Column (B) - Program Services = $924; Column (C) - Management & General = $0; Column (D) - Fundraising = $0
Form 990, Part IX, Line 24e: Other ExpensesNANOWAFER PROJECT: Column (A) - Total = $5988; Column (B) - Program Services = $5988; Column (C) - Management & General = $0; Column (D) - Fundraising = $0
Form 990, Part IX, Line 24e: Other ExpensesOTHER EXPENSES: Column (A) - Total = $64295; Column (B) - Program Services = $178; Column (C) - Management & General = $862; Column (D) - Fundraising = $63255
Form 990, Part IX, Line 24e: Other ExpensesPATIENT REGISTRY: Column (A) - Total = $12135; Column (B) - Program Services = $12135; Column (C) - Management & General = $0; Column (D) - Fundraising = $0
Form 990, Part IX, Line 24e: Other ExpensesPHOTOGRAPHY: Column (A) - Total = $44797; Column (B) - Program Services = $0; Column (C) - Management & General = $0; Column (D) - Fundraising = $44797
Form 990, Part IX, Line 24e: Other ExpensesPostage and Shipping: Column (A) - Total = $13824; Column (B) - Program Services = $0; Column (C) - Management & General = $3612; Column (D) - Fundraising = $10212
Form 990, Part IX, Line 24e: Other ExpensesSUPPLIES: Column (A) - Total = $35257; Column (B) - Program Services = $0; Column (C) - Management & General = $1222; Column (D) - Fundraising = $34035
Form 990, Part IX, Line 24e: Other ExpensesSYMPOSIUM: Column (A) - Total = $93196; Column (B) - Program Services = $93196; Column (C) - Management & General = $0; Column (D) - Fundraising = $0
Form 990, Part IX, Line 24e: Other ExpensesTELEPHONE: Column (A) - Total = $1717; Column (B) - Program Services = $0; Column (C) - Management & General = $1717; Column (D) - Fundraising = $0
Form 990, Part IX, Line 24e: Other ExpensesTOURNAMENT SITE: Column (A) - Total = $11363; Column (B) - Program Services = $0; Column (C) - Management & General = $0; Column (D) - Fundraising = $11363
Form 990, Part IX, Line 24e: Other ExpensesWEBSITE: Column (A) - Total = $24757; Column (B) - Program Services = $0; Column (C) - Management & General = $21001; Column (D) - Fundraising = $3756

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.